Co-spray dried inhalable composite powders of ciprofloxacin and alginate oligosaccharide as anti-biofilm therapy.

[1]  H. Kafil,et al.  Novel Strategies to Combat Bacterial Biofilms , 2021, Molecular Biotechnology.

[2]  Niall J. O'Reilly,et al.  Leucine as an excipient in spray dried powder for inhalation. , 2021, Drug discovery today.

[3]  J. Kutter,et al.  Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria. , 2020, International journal of pharmaceutics.

[4]  A. Douvalis,et al.  Ciprofloxacin conjugated to diphenyltin(iv): a novel formulation with enhanced antimicrobial activity. , 2020, Dalton transactions.

[5]  M. Kang,et al.  Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability , 2019, Pharmaceutics.

[6]  K. Winnicka,et al.  Alginate Oligosaccharides Affect Mechanical Properties and Antifungal Activity of Alginate Buccal Films with Posaconazole , 2019, Marine drugs.

[7]  G. Cook,et al.  Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies , 2019, Pharmaceutics.

[8]  Jian Li,et al.  Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  G. Chinga-Carrasco,et al.  Cellulose nanofibril formulations incorporating a low molecular weight alginate oligosaccharide modify bacterial biofilm development. , 2019, Biomacromolecules.

[10]  T. Rades,et al.  Design of Inhalable Solid Dosage Forms of Budesonide and Theophylline for Pulmonary Combination Therapy , 2019, AAPS PharmSciTech.

[11]  Mingshi Yang,et al.  Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying , 2018, Pharmaceutical Research.

[12]  Sonal V. Bhujbal,et al.  Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin. , 2018, Molecular pharmaceutics.

[13]  N. Buurma,et al.  Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides , 2018, npj Biofilms and Microbiomes.

[14]  Sonal V. Bhujbal,et al.  Influence of excipients on physical and aerosolization stability of spray dried high‐dose powder formulations for inhalation , 2018, International journal of pharmaceutics.

[15]  C. Doyle,et al.  The influence of surface active L‐leucine and 1,2‐dipalmitoyl‐sn‐glycero‐3‐phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co‐spray dried powders , 2018, International journal of pharmaceutics.

[16]  S. Ibrić,et al.  Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling. , 2018, International journal of pharmaceutics.

[17]  J. Elborn,et al.  Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug-device combination. , 2018, Pulmonary pharmacology & therapeutics.

[18]  T. Webster,et al.  Azithromycin-loaded respirable microparticles for targeted pulmonary delivery for the treatment of pneumonia. , 2018, Biomaterials.

[19]  K. Beck,et al.  Alginate Oligosaccharide-Induced Modification of the lasI-lasR and rhlI-rhlR Quorum-Sensing Systems in Pseudomonas aeruginosa , 2018, Antimicrobial Agents and Chemotherapy.

[20]  A. Healy,et al.  New aerosol formulation to control ciprofloxacin pulmonary concentration , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Jukka Rantanen,et al.  Budesonide nanocrystal-loaded hyaluronic acid microparticles for inhalation: In vitro and in vivo evaluation. , 2018, Carbohydrate polymers.

[22]  Paul Stoodley,et al.  Targeting microbial biofilms: current and prospective therapeutic strategies , 2017, Nature Reviews Microbiology.

[23]  T. Gengenbach,et al.  Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation. , 2017, International journal of pharmaceutics.

[24]  C. Doyle,et al.  Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis. , 2017, International journal of pharmaceutics.

[25]  K. Beck,et al.  A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness , 2017, Antimicrobial Agents and Chemotherapy.

[26]  T. Gengenbach,et al.  L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  M. Kappl,et al.  Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability , 2016, Expert opinion on drug delivery.

[28]  N. Høiby,et al.  OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model , 2016, Antimicrobial Agents and Chemotherapy.

[29]  J. Weers.  Inhaled antimicrobial therapy - barriers to effective treatment. , 2015, Advanced drug delivery reviews.

[30]  A. Oliver,et al.  ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  T. Tolker-Nielsen,et al.  Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. , 2015, Advanced drug delivery reviews.

[32]  Li Yang,et al.  Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: a case study of lovastatin. , 2015, Colloids and surfaces. B, Biointerfaces.

[33]  W. Britton,et al.  A Rifapentine-Containing Inhaled Triple Antibiotic Formulation for Rapid Treatment of Tubercular Infection , 2014, Pharmaceutical Research.

[34]  Wei Wu,et al.  Understanding the relationship between wettability and dissolution of solid dispersion. , 2014, International journal of pharmaceutics.

[35]  R. Davé,et al.  A study of the physical stability of wet media-milled fenofibrate suspensions using dynamic equilibrium curves , 2013 .

[36]  I. El-Sherbiny,et al.  Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles. , 2012, Molecular pharmaceutics.

[37]  Sérgio M. Santos,et al.  Packing interactions in hydrated and anhydrous forms of the antibiotic Ciprofloxacin: a solid-state NMR, X-ray diffraction, and computer simulation study. , 2012, Journal of the American Chemical Society.

[38]  K. A. Kumar,et al.  Fluoroquinolone salts with carboxylic acids. , 2011, Journal of pharmaceutical sciences.

[39]  E. Fattal,et al.  Formulation and in vivo evaluation of sodium alendronate spray-dried microparticles intended for lung delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[40]  T. Row,et al.  A Device to Crystallize Organic Solids: Structure of Ciprofloxacin, Midazolam, and Ofloxacin as Targets , 2010 .

[41]  G. O’Toole,et al.  Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. , 2009, American journal of respiratory cell and molecular biology.

[42]  K. Paeng,et al.  Preparation of Alginic Acid and Metal Alginate from Algae and their Comparative Study , 2008 .

[43]  G. Rowley,et al.  The Effect of Relative Humidity on Electrostatic Charge Decay of Drugs and Excipient Used in Dry Powder Inhaler Formulation , 2007, Drug development and industrial pharmacy.

[44]  P. Seville,et al.  The influence of formulation components on the aerosolisation properties of spray-dried powders. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[45]  N. Chew,et al.  Effect of amino acids on the dispersion of disodium cromoglycate powders. , 2005, Journal of pharmaceutical sciences.

[46]  J. Emerson,et al.  Clinically Feasible Biofilm Susceptibility Assay for Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis , 2004, Journal of Clinical Microbiology.

[47]  P. Bukovec,et al.  Crystal structure of ciprofloxacin hexahydrate and its characterization , 1997 .

[48]  J. Buchanan-Smith,et al.  A colorimetric method for the quantitation of uronic acids and a specific assay for galacturonic acid. , 1992, Analytical biochemistry.

[49]  V. Dhawan,et al.  Ciprofloxacin: in vitro, experimental, and clinical evaluation. , 1988, Reviews of infectious diseases.

[50]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .